• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重脓毒症和脓毒性休克:管理和绩效改进。

Severe sepsis and septic shock: management and performance improvement.

机构信息

Division of Critical Care Medicine; Department of Medicine; Cooper University Hospital; Camden, NJ USA.

出版信息

Virulence. 2014 Jan 1;5(1):190-9. doi: 10.4161/viru.27409. Epub 2013 Dec 11.

DOI:10.4161/viru.27409
PMID:24335487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3916373/
Abstract

Morbidity and mortality from sepsis remains unacceptably high. Large variability in clinical practice, plus the increasing awareness that certain processes of care associated with improved critical care outcomes, has led to the development of clinical practice guidelines in a variety of areas related to infection and sepsis. The Surviving Sepsis Guidelines for Management of Severe Sepsis and Septic Shock were first published in 2004, revised in 2008, and recently revised again and published in 2013. The first part of this manuscript is a summary of the 2013 guidelines with some editorial comment. The second part of the manuscript characterizes hospital based sepsis performance improvement programs and highlights the sepsis bundles from the Surviving Sepsis Campaign as a key component of such a program.

摘要

脓毒症的发病率和死亡率仍然高得令人无法接受。临床实践中的巨大差异,加上人们越来越意识到某些与改善重症监护结果相关的护理过程,导致了与感染和脓毒症相关的各种领域的临床实践指南的发展。《严重脓毒症和脓毒性休克管理的存活脓毒症指南》于 2004 年首次发表,2008 年修订,最近再次修订并于 2013 年发表。本文稿的第一部分是 2013 年指南的摘要,并附有一些社论评论。本文稿的第二部分描述了基于医院的脓毒症改善计划,并强调了来自拯救脓毒症运动的脓毒症捆绑作为该计划的关键组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/3916373/a0598756780e/viru-5-190-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/3916373/e860689d3f79/viru-5-190-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/3916373/a0598756780e/viru-5-190-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/3916373/e860689d3f79/viru-5-190-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd5/3916373/a0598756780e/viru-5-190-g2.jpg

相似文献

1
Severe sepsis and septic shock: management and performance improvement.严重脓毒症和脓毒性休克:管理和绩效改进。
Virulence. 2014 Jan 1;5(1):190-9. doi: 10.4161/viru.27409. Epub 2013 Dec 11.
2
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.拯救脓毒症运动:严重脓毒症和脓毒性休克治疗国际指南:2008年版
Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41.
3
Treatment of Pediatric Septic Shock With the Surviving Sepsis Campaign Guidelines and PICU Patient Outcomes.采用脓毒症存活策略指南治疗小儿脓毒性休克及儿科重症监护病房患者的预后
Pediatr Crit Care Med. 2016 Oct;17(10):e451-e458. doi: 10.1097/PCC.0000000000000906.
4
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.经验性抗生素治疗从第一小时起即可降低严重脓毒症和脓毒性休克的死亡率:基于指南的绩效改进项目结果
Crit Care Med. 2014 Aug;42(8):1749-55. doi: 10.1097/CCM.0000000000000330.
5
Controversies of surviving sepsis campaign bundles: should we use them?脓毒症存活策略集束化治疗的争议:我们应该使用它们吗?
Shock. 2008 Oct;30 Suppl 1:34-40. doi: 10.1097/SHK.0b013e3181819df1.
6
Reducing mortality in severe sepsis: the Surviving Sepsis Campaign.降低严重脓毒症的死亡率:拯救脓毒症运动
Clin Chest Med. 2008 Dec;29(4):721-33, x. doi: 10.1016/j.ccm.2008.06.011.
7
Advances in the management of sepsis: the randomised controlled trials behind the Surviving Sepsis Campaign recommendations.脓毒症管理的进展:拯救脓毒症运动推荐背后的随机对照试验
Int J Antimicrob Agents. 2006 Feb;27(2):97-101. doi: 10.1016/j.ijantimicag.2005.11.003. Epub 2006 Jan 18.
8
Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign.成人脓毒性休克中低剂量类固醇:脓毒症存活运动的结果。
Intensive Care Med. 2012 Dec;38(12):1946-54. doi: 10.1007/s00134-012-2720-z. Epub 2012 Oct 12.
9
[Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].[降钙素原在监测脓毒症外科患者抗生素治疗中的作用]
Chirurgia (Bucur). 2012 Jan-Feb;107(1):71-8.
10
Implementing a collaborative protocol in a sepsis intervention program: lessons learned.在脓毒症干预项目中实施协作方案:经验教训。
Lung. 2011 Feb;189(1):11-9. doi: 10.1007/s00408-010-9266-z. Epub 2010 Nov 16.

引用本文的文献

1
Efficacy and Safety of a Balanced Gelatine Solution for Fluid Resuscitation in Sepsis: A Prospective, Randomised, Controlled, Double-Blind Trial-GENIUS Trial.一种平衡明胶溶液用于脓毒症液体复苏的有效性和安全性:一项前瞻性、随机、对照、双盲试验——GENIUS试验
J Clin Med. 2025 Jul 28;14(15):5323. doi: 10.3390/jcm14155323.
2
Systemic Inflammatory Response Syndrome, Thromboinflammation, and Septic Shock in Fetuses and Neonates.胎儿和新生儿的全身炎症反应综合征、血栓炎症和感染性休克
Int J Mol Sci. 2025 Apr 1;26(7):3259. doi: 10.3390/ijms26073259.
3
The chain of survival and rehabilitation for sepsis: concepts and proposals for healthcare trajectory optimization.

本文引用的文献

1
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
2
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.危重症患者血糖管理中应用胰岛素输注的指南。
Crit Care Med. 2012 Dec;40(12):3251-76. doi: 10.1097/CCM.0b013e3182653269.
3
Hydroxyethyl starch or saline for fluid resuscitation in intensive care.
脓毒症生存与康复链:医疗轨迹优化的概念与建议
Ann Intensive Care. 2024 Apr 16;14(1):58. doi: 10.1186/s13613-024-01282-6.
4
Phosphorylation-mediated PI3K-Art signalling pathway as a therapeutic mechanism in the hydrogen-induced alleviation of brain injury in septic mice.磷酸化介导的 PI3K-Akt 信号通路作为氢气减轻脓毒症小鼠脑损伤的治疗机制。
J Cell Mol Med. 2022 Nov;26(22):5713-5727. doi: 10.1111/jcmm.17568. Epub 2022 Oct 29.
5
The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis.拯救脓毒症运动:脓毒症管理、流行病学、评分及识别方面的研究重点
Intensive Care Med Exp. 2021 Jul 2;9(1):34. doi: 10.1186/s40635-021-00400-z.
6
Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsis.早期目标控制胶体容量复苏与平衡电解质溶液复苏对严重脓毒症/脓毒性休克患者的疗效和安全性:一项前瞻性、随机、对照、双盲、多中心、国际临床试验的研究方案、设计和原理:GENIUS-Gel 用于 ICU 和脓毒症。
Trials. 2021 Jun 2;22(1):376. doi: 10.1186/s13063-021-05311-8.
7
Capsaicin protects cardiomyocytes against lipopolysaccharide-induced damage via 14-3-3γ-mediated autophagy augmentation.辣椒素通过14-3-3γ介导的自噬增强保护心肌细胞免受脂多糖诱导的损伤。
Front Pharmacol. 2021 Apr 27;12:659015. doi: 10.3389/fphar.2021.659015. eCollection 2021.
8
Ablation of Aquaporin-9 Ameliorates the Systemic Inflammatory Response of LPS-Induced Endotoxic Shock in Mouse.水通道蛋白-9 的消融可改善 LPS 诱导的内毒素休克小鼠的全身炎症反应。
Cells. 2021 Feb 18;10(2):435. doi: 10.3390/cells10020435.
9
iTRAQ-Based Quantitative Proteomic Analysis of Intestines in Murine Polymicrobial Sepsis with Hydrogen Gas Treatment.氢气处理对多微生物脓毒症小鼠肠道的 iTRAQ 定量蛋白质组学分析。
Drug Des Devel Ther. 2020 Nov 12;14:4885-4900. doi: 10.2147/DDDT.S271191. eCollection 2020.
10
An evaluation of suspected cases of Hantavirus infection admitted to a tertiary care university hospital in Düzce, Turkey, between 2012 and 2018.土耳其迪兹杰省一家三级教学医院 2012 至 2018 年期间疑似汉坦病毒感染病例评估。
Turk J Med Sci. 2021 Feb 26;51(1):288-296. doi: 10.3906/sag-1912-123.
羟乙基淀粉或生理盐水用于重症监护中的液体复苏。
N Engl J Med. 2012 Nov 15;367(20):1901-11. doi: 10.1056/NEJMoa1209759. Epub 2012 Oct 17.
4
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.羟乙基淀粉 130/0.42 与醋酸林格氏液治疗严重脓毒症的比较。
N Engl J Med. 2012 Jul 12;367(2):124-34. doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27.
5
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study.6%羟乙基淀粉130/0.4与0.9%氯化钠用于严重脓毒症患者液体复苏的血流动力学疗效及安全性评估:CRYSTMAS研究
Crit Care. 2012 May 24;16(3):R94. doi: 10.1186/cc11358.
6
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.执行摘要:《抗栓治疗与血栓形成预防》第9版:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):7S-47S. doi: 10.1378/chest.1412S3.
7
Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.静脉内β-2 激动剂治疗对急性呼吸窘迫综合征临床结局的影响(BALTI-2):一项多中心、随机对照试验。
Lancet. 2012 Jan 21;379(9812):229-35. doi: 10.1016/S0140-6736(11)61623-1. Epub 2011 Dec 11.
8
Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.多巴胺与去甲肾上腺素治疗脓毒性休克的比较:一项荟萃分析*。
Crit Care Med. 2012 Mar;40(3):725-30. doi: 10.1097/CCM.0b013e31823778ee.
9
Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.低剂量氢化可的松治疗脓毒性休克患者:3 天与 7 天比较的初步研究。
Respirology. 2011 Oct;16(7):1088-95. doi: 10.1111/j.1440-1843.2011.02018.x.
10
Early versus late parenteral nutrition in critically ill adults.危重症成人的早期与晚期肠外营养。
N Engl J Med. 2011 Aug 11;365(6):506-17. doi: 10.1056/NEJMoa1102662. Epub 2011 Jun 29.